Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

38.43
Delayed Data
As of Dec 05
 +0.53 / +1.40%
Today’s Change
36.00
Today|||52-Week Range
46.22
-14.43%
Year-to-Date
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
The Best Obamacare Stocks of 2016
Nov 29 / MotleyFool.com - Paid Partner Content
Abbott's i-STAT Alinity Received CE Mark
Nov 30 / GuruFocus News - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content

Today’s Trading

Previous close37.90
Today’s open38.11
Day’s range37.99 - 38.45
Volume9,514,677
Average volume (3 months)8,950,948
Market cap$55.8B
Dividend yield2.71%
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+18.14%
Earnings growth (this year)+2.66%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.78%
P/E ratio58.2
Price/Sales3.31
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
SHPGShire+1.59+0.91%
AZNAstraZeneca-0.07-0.27%
NVONovo Nordisk+0.49+1.44%
AGNAllergan+1.49+0.79%
Data as of 12/05/2016

Financials

Next reporting dateJanuary 25, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts


Search for Jobs